Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Boston Biomedical
Boston Biomedical
Sumitomo merges U.S. biotechs to create oncology division
Fierce Biotech
Wed, 07/1/20 - 11:04 am
Sumitomo Dainippon
Tolero Pharmaceuticals
Boston Biomedical
oncology
M&A
Pancreatic Cancer Update: Abandoned Trial, Exciting Research, New Appointments
BioSpace
Tue, 07/2/19 - 11:52 pm
pancreatic cancer
Boston Biomedical
Cold Spring Harbor Laboratory
PanCan
Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test
Fierce Biotech
Tue, 07/2/19 - 10:30 am
Boston Biomedical
clinical trials
pancreatic cancer
napabucasin
PhIII flop for top Boston cancer stem cell program batters Dainippon Sumitomo
Fierce Biotech
Tue, 05/27/14 - 10:06 am
stem cells
Dainippon Sumitomo
Boston Biomedical
BB1608
colorectal cancer
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron